Sex difference in Aroclor 1254 induction of rat hepatocytes: Consequences for in vitro embryotoxicity and mutagenicity of cyclophosphamide
The sequential culture of rat hepatocytes and post-implantation rat embryos has been proposed as a model for the in vitro testing of pro-teratogens. Comparing this model with a model in which embryos and hepatocytes are cultured simultaneously a striking difference in sensitivity was noted. To addre...
Gespeichert in:
Veröffentlicht in: | Toxicology in vitro 1993-11, Vol.7 (6), p.769-775 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 775 |
---|---|
container_issue | 6 |
container_start_page | 769 |
container_title | Toxicology in vitro |
container_volume | 7 |
creator | van Aerts, L.A.G.J.M. Hahné, S.J.M. Oostendorp, A.G.M. Pertijs, J.C.L.M. Fijneman, P.H.S. Bos, R.P. Copius Peereboom, J.H.J. Noordhoek, J. |
description | The sequential culture of rat hepatocytes and post-implantation rat embryos has been proposed as a model for the
in vitro testing of pro-teratogens. Comparing this model with a model in which embryos and hepatocytes are cultured simultaneously a striking difference in sensitivity was noted. To address the question of whether this difference could be explained by different sex and/or Aroclor 1254 pretreatment of the rats providing the hepatocytes, an experiment was designed with four groups: male Aroclor 1254 pretreated (M
1), male untreated, pregnant female Aroclor 1254 pretreated (F
1) and pregnant female untreated rats. Hepatocytes were incubated in the presence of cyclophosphamide (CP) and rat embryos were cultured in the media derived from the hepatocyte culture (i.e. the sequential culture model). Additionally, the CP concentrations of the media were analysed and subsequently the media were tested in a bacterial mutagenicity test (
Salmonella typhimurium TA1535). With a CP concentration of 300 μ
m, M
1 produced maximum embryotoxicity and mutagenicity after 4 hr of hepatocytes incubation. All other groups showed no or only a slight increase in embryotoxicity and mutagenicity for all hepatocyte incubations. M
1 was also quickest to eliminate CP from the medium. These results indicate that despite a strong increase in total cytochrome
P-450 in both sexes as a result of Aroclor 1254 pretreatment, and in the absence of a significant difference in total cytochrome
P-450 between M
1 and F
1, Aroclor 1254 pretreatment has a much more pronounced effect in male rats than in pregnant female rats with regard to the production of embryotoxic and mutagenic metabolites of CP. |
doi_str_mv | 10.1016/0887-2333(93)90080-O |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_748995633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>088723339390080O</els_id><sourcerecordid>16802591</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-c83b4dd7032208b8bc9aa4fa1aa8c55ad02ef1b1988361678585d83cce3d28593</originalsourceid><addsrcrecordid>eNp9kcuKFDEUhoMoTtv6BiJZiJdFaVKpy4kLYWi8wUAv1HVIJafsSFWlTVLD1Cv41KbotpcDgZDw_Scn5yPkOWfvOOPNewbQFqUQ4o0UbyVjwIr9A7Lh0MpC8LZ9SDYX5Io8ifE3Y6yGkj0mVyVrRVm2ckP-fsc7al3fY8DJIHUTvQ7eDD5QXtZVPtvZJOcn6nsadKIHPOrkzZIwfqA7P0X8M6_JSPucyfFbl4KnOHZh8cnfOePSQvVk6Tgn_Qun00WuZpb8zPHg4_GgR2fxKXnU6yHis_O-JT8_f_qx-1rc7L98213fFKbiMhUGRFdZ27L8AwYddEZqXfWaaw2mrrVlJfa84xJANLxpoYbagjAGhS2hlmJLXp_qHoPPvcekRhcNDoOe0M9RtRVIWTd5bFvy6l6SN8DKWvIMVifQBB9jwF4dgxt1WBRnarWlVhVqVaFkXqsttc-xF-f6czeivYT-68nAyzOgo9FDH_RkXLxwAoBXvMnYxxOGeWy3DoOKxq1SrAtokrLe3d_IP2t-suA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16802591</pqid></control><display><type>article</type><title>Sex difference in Aroclor 1254 induction of rat hepatocytes: Consequences for in vitro embryotoxicity and mutagenicity of cyclophosphamide</title><source>Access via ScienceDirect (Elsevier)</source><creator>van Aerts, L.A.G.J.M. ; Hahné, S.J.M. ; Oostendorp, A.G.M. ; Pertijs, J.C.L.M. ; Fijneman, P.H.S. ; Bos, R.P. ; Copius Peereboom, J.H.J. ; Noordhoek, J.</creator><creatorcontrib>van Aerts, L.A.G.J.M. ; Hahné, S.J.M. ; Oostendorp, A.G.M. ; Pertijs, J.C.L.M. ; Fijneman, P.H.S. ; Bos, R.P. ; Copius Peereboom, J.H.J. ; Noordhoek, J.</creatorcontrib><description>The sequential culture of rat hepatocytes and post-implantation rat embryos has been proposed as a model for the
in vitro testing of pro-teratogens. Comparing this model with a model in which embryos and hepatocytes are cultured simultaneously a striking difference in sensitivity was noted. To address the question of whether this difference could be explained by different sex and/or Aroclor 1254 pretreatment of the rats providing the hepatocytes, an experiment was designed with four groups: male Aroclor 1254 pretreated (M
1), male untreated, pregnant female Aroclor 1254 pretreated (F
1) and pregnant female untreated rats. Hepatocytes were incubated in the presence of cyclophosphamide (CP) and rat embryos were cultured in the media derived from the hepatocyte culture (i.e. the sequential culture model). Additionally, the CP concentrations of the media were analysed and subsequently the media were tested in a bacterial mutagenicity test (
Salmonella typhimurium TA1535). With a CP concentration of 300 μ
m, M
1 produced maximum embryotoxicity and mutagenicity after 4 hr of hepatocytes incubation. All other groups showed no or only a slight increase in embryotoxicity and mutagenicity for all hepatocyte incubations. M
1 was also quickest to eliminate CP from the medium. These results indicate that despite a strong increase in total cytochrome
P-450 in both sexes as a result of Aroclor 1254 pretreatment, and in the absence of a significant difference in total cytochrome
P-450 between M
1 and F
1, Aroclor 1254 pretreatment has a much more pronounced effect in male rats than in pregnant female rats with regard to the production of embryotoxic and mutagenic metabolites of CP.</description><identifier>ISSN: 0887-2333</identifier><identifier>EISSN: 1879-3177</identifier><identifier>DOI: 10.1016/0887-2333(93)90080-O</identifier><identifier>PMID: 20732279</identifier><identifier>CODEN: TIVIEQ</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Drug toxicity and drugs side effects treatment ; Medical sciences ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments</subject><ispartof>Toxicology in vitro, 1993-11, Vol.7 (6), p.769-775</ispartof><rights>1993</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-c83b4dd7032208b8bc9aa4fa1aa8c55ad02ef1b1988361678585d83cce3d28593</citedby><cites>FETCH-LOGICAL-c419t-c83b4dd7032208b8bc9aa4fa1aa8c55ad02ef1b1988361678585d83cce3d28593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0887-2333(93)90080-O$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3881416$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20732279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Aerts, L.A.G.J.M.</creatorcontrib><creatorcontrib>Hahné, S.J.M.</creatorcontrib><creatorcontrib>Oostendorp, A.G.M.</creatorcontrib><creatorcontrib>Pertijs, J.C.L.M.</creatorcontrib><creatorcontrib>Fijneman, P.H.S.</creatorcontrib><creatorcontrib>Bos, R.P.</creatorcontrib><creatorcontrib>Copius Peereboom, J.H.J.</creatorcontrib><creatorcontrib>Noordhoek, J.</creatorcontrib><title>Sex difference in Aroclor 1254 induction of rat hepatocytes: Consequences for in vitro embryotoxicity and mutagenicity of cyclophosphamide</title><title>Toxicology in vitro</title><addtitle>Toxicol In Vitro</addtitle><description>The sequential culture of rat hepatocytes and post-implantation rat embryos has been proposed as a model for the
in vitro testing of pro-teratogens. Comparing this model with a model in which embryos and hepatocytes are cultured simultaneously a striking difference in sensitivity was noted. To address the question of whether this difference could be explained by different sex and/or Aroclor 1254 pretreatment of the rats providing the hepatocytes, an experiment was designed with four groups: male Aroclor 1254 pretreated (M
1), male untreated, pregnant female Aroclor 1254 pretreated (F
1) and pregnant female untreated rats. Hepatocytes were incubated in the presence of cyclophosphamide (CP) and rat embryos were cultured in the media derived from the hepatocyte culture (i.e. the sequential culture model). Additionally, the CP concentrations of the media were analysed and subsequently the media were tested in a bacterial mutagenicity test (
Salmonella typhimurium TA1535). With a CP concentration of 300 μ
m, M
1 produced maximum embryotoxicity and mutagenicity after 4 hr of hepatocytes incubation. All other groups showed no or only a slight increase in embryotoxicity and mutagenicity for all hepatocyte incubations. M
1 was also quickest to eliminate CP from the medium. These results indicate that despite a strong increase in total cytochrome
P-450 in both sexes as a result of Aroclor 1254 pretreatment, and in the absence of a significant difference in total cytochrome
P-450 between M
1 and F
1, Aroclor 1254 pretreatment has a much more pronounced effect in male rats than in pregnant female rats with regard to the production of embryotoxic and mutagenic metabolites of CP.</description><subject>Biological and medical sciences</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Medical sciences</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><issn>0887-2333</issn><issn>1879-3177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNp9kcuKFDEUhoMoTtv6BiJZiJdFaVKpy4kLYWi8wUAv1HVIJafsSFWlTVLD1Cv41KbotpcDgZDw_Scn5yPkOWfvOOPNewbQFqUQ4o0UbyVjwIr9A7Lh0MpC8LZ9SDYX5Io8ifE3Y6yGkj0mVyVrRVm2ckP-fsc7al3fY8DJIHUTvQ7eDD5QXtZVPtvZJOcn6nsadKIHPOrkzZIwfqA7P0X8M6_JSPucyfFbl4KnOHZh8cnfOePSQvVk6Tgn_Qun00WuZpb8zPHg4_GgR2fxKXnU6yHis_O-JT8_f_qx-1rc7L98213fFKbiMhUGRFdZ27L8AwYddEZqXfWaaw2mrrVlJfa84xJANLxpoYbagjAGhS2hlmJLXp_qHoPPvcekRhcNDoOe0M9RtRVIWTd5bFvy6l6SN8DKWvIMVifQBB9jwF4dgxt1WBRnarWlVhVqVaFkXqsttc-xF-f6czeivYT-68nAyzOgo9FDH_RkXLxwAoBXvMnYxxOGeWy3DoOKxq1SrAtokrLe3d_IP2t-suA</recordid><startdate>19931101</startdate><enddate>19931101</enddate><creator>van Aerts, L.A.G.J.M.</creator><creator>Hahné, S.J.M.</creator><creator>Oostendorp, A.G.M.</creator><creator>Pertijs, J.C.L.M.</creator><creator>Fijneman, P.H.S.</creator><creator>Bos, R.P.</creator><creator>Copius Peereboom, J.H.J.</creator><creator>Noordhoek, J.</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19931101</creationdate><title>Sex difference in Aroclor 1254 induction of rat hepatocytes: Consequences for in vitro embryotoxicity and mutagenicity of cyclophosphamide</title><author>van Aerts, L.A.G.J.M. ; Hahné, S.J.M. ; Oostendorp, A.G.M. ; Pertijs, J.C.L.M. ; Fijneman, P.H.S. ; Bos, R.P. ; Copius Peereboom, J.H.J. ; Noordhoek, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-c83b4dd7032208b8bc9aa4fa1aa8c55ad02ef1b1988361678585d83cce3d28593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Biological and medical sciences</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Medical sciences</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Aerts, L.A.G.J.M.</creatorcontrib><creatorcontrib>Hahné, S.J.M.</creatorcontrib><creatorcontrib>Oostendorp, A.G.M.</creatorcontrib><creatorcontrib>Pertijs, J.C.L.M.</creatorcontrib><creatorcontrib>Fijneman, P.H.S.</creatorcontrib><creatorcontrib>Bos, R.P.</creatorcontrib><creatorcontrib>Copius Peereboom, J.H.J.</creatorcontrib><creatorcontrib>Noordhoek, J.</creatorcontrib><collection>Pascal-Francis</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Toxicology in vitro</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Aerts, L.A.G.J.M.</au><au>Hahné, S.J.M.</au><au>Oostendorp, A.G.M.</au><au>Pertijs, J.C.L.M.</au><au>Fijneman, P.H.S.</au><au>Bos, R.P.</au><au>Copius Peereboom, J.H.J.</au><au>Noordhoek, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sex difference in Aroclor 1254 induction of rat hepatocytes: Consequences for in vitro embryotoxicity and mutagenicity of cyclophosphamide</atitle><jtitle>Toxicology in vitro</jtitle><addtitle>Toxicol In Vitro</addtitle><date>1993-11-01</date><risdate>1993</risdate><volume>7</volume><issue>6</issue><spage>769</spage><epage>775</epage><pages>769-775</pages><issn>0887-2333</issn><eissn>1879-3177</eissn><coden>TIVIEQ</coden><abstract>The sequential culture of rat hepatocytes and post-implantation rat embryos has been proposed as a model for the
in vitro testing of pro-teratogens. Comparing this model with a model in which embryos and hepatocytes are cultured simultaneously a striking difference in sensitivity was noted. To address the question of whether this difference could be explained by different sex and/or Aroclor 1254 pretreatment of the rats providing the hepatocytes, an experiment was designed with four groups: male Aroclor 1254 pretreated (M
1), male untreated, pregnant female Aroclor 1254 pretreated (F
1) and pregnant female untreated rats. Hepatocytes were incubated in the presence of cyclophosphamide (CP) and rat embryos were cultured in the media derived from the hepatocyte culture (i.e. the sequential culture model). Additionally, the CP concentrations of the media were analysed and subsequently the media were tested in a bacterial mutagenicity test (
Salmonella typhimurium TA1535). With a CP concentration of 300 μ
m, M
1 produced maximum embryotoxicity and mutagenicity after 4 hr of hepatocytes incubation. All other groups showed no or only a slight increase in embryotoxicity and mutagenicity for all hepatocyte incubations. M
1 was also quickest to eliminate CP from the medium. These results indicate that despite a strong increase in total cytochrome
P-450 in both sexes as a result of Aroclor 1254 pretreatment, and in the absence of a significant difference in total cytochrome
P-450 between M
1 and F
1, Aroclor 1254 pretreatment has a much more pronounced effect in male rats than in pregnant female rats with regard to the production of embryotoxic and mutagenic metabolites of CP.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>20732279</pmid><doi>10.1016/0887-2333(93)90080-O</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0887-2333 |
ispartof | Toxicology in vitro, 1993-11, Vol.7 (6), p.769-775 |
issn | 0887-2333 1879-3177 |
language | eng |
recordid | cdi_proquest_miscellaneous_748995633 |
source | Access via ScienceDirect (Elsevier) |
subjects | Biological and medical sciences Drug toxicity and drugs side effects treatment Medical sciences Miscellaneous (drug allergy, mutagens, teratogens...) Pharmacology. Drug treatments |
title | Sex difference in Aroclor 1254 induction of rat hepatocytes: Consequences for in vitro embryotoxicity and mutagenicity of cyclophosphamide |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T17%3A13%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sex%20difference%20in%20Aroclor%201254%20induction%20of%20rat%20hepatocytes:%20Consequences%20for%20in%20vitro%20embryotoxicity%20and%20mutagenicity%20of%20cyclophosphamide&rft.jtitle=Toxicology%20in%20vitro&rft.au=van%20Aerts,%20L.A.G.J.M.&rft.date=1993-11-01&rft.volume=7&rft.issue=6&rft.spage=769&rft.epage=775&rft.pages=769-775&rft.issn=0887-2333&rft.eissn=1879-3177&rft.coden=TIVIEQ&rft_id=info:doi/10.1016/0887-2333(93)90080-O&rft_dat=%3Cproquest_cross%3E16802591%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16802591&rft_id=info:pmid/20732279&rft_els_id=088723339390080O&rfr_iscdi=true |